You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JAK2V617F mutation

Showing 1 - 25 of 3,922
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carotid Plaque Burden in Philadelphia Negative

Recruiting
  • Myeloproliferative Neoplasm
    • Sohag, Egypt
      Faculty of Medicine
    Aug 14, 2023

    Patients With ET Treated With XAGRID®

    Completed
    Has Results
    • Essential Thrombocythemia (ET)
    • Anagrelide hydrochloride
    • Bari, Italy
    • +9 more
    Jul 6, 2021

    Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

    Not yet recruiting
    • Polycythemia Vera
    • Givinostat Hydrochloride
    • Hydroxy Urea
    • (no location specified)
    Oct 19, 2023

    Arterial Function and Atherosclerosis in Essential

    Completed
    Has Results
    • Atherosclerosis
    • imaging
    • (no location specified)
    Oct 6, 2021

    Thrombotic Complications (CLOJAK)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Blood sampling
    • Angers, France
    • +10 more
    Apr 20, 2023

    Anticoagulation in Gastroesophageal Varices and JAK2 Mutation

    Not yet recruiting
    • Gastroesophageal Varices
    • +2 more
    • Anticoagulation Agents
    • (no location specified)
    Aug 25, 2020

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Biopsy
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Nov 17, 2023

    Myeloproliferative Tumor, Splanchnic Vein Thrombosis, JAK2 V617 Trial in London (Drugs, procedures)

    Enrolling by invitation
    • Myeloproliferative Neoplasm
    • +2 more
    • Drugs, procedures
    • London, United Kingdom
      Royal Free London Hospital
    Jul 29, 2021

    Action of Interferon in Treatment of Myeloproliferative

    Recruiting
    • Myeloproliferative Neoplasm
      • Villejuif, Ile De France, France
        Inserm U1287
      Apr 28, 2023

      Polycythemia Vera Trial in Oklahoma City (Erlotinib)

      Terminated
      Has Results
      • Polycythemia Vera
      • Oklahoma City, Oklahoma
        University of Oklahoma Health Sciences Center
      Aug 7, 2020

      Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution

      Recruiting
      • Polycythemia Vera
        • Sohag, Egypt
          Faculty of Medicine
        Aug 12, 2023

        Monocytes Sub-populations in Thrombosis Associated With

        Recruiting
        • Myeloproliferative Neoplasm
        • 1 additional tube of blood
        • Bordeaux, France
        • +4 more
        Nov 30, 2022

        Thrombosis in Myeloproliferative Neoplasms

        Completed
        • Myeloproliferative Neoplasm
        • 2 additional tubes of blood
        • Angers, France
        • +23 more
        Aug 17, 2022

        Myelofibrosis Trial in Gilbert, Houston (APG-1252, Ruxolitinib)

        Withdrawn
        • Myelofibrosis
        • Gilbert, Arizona
        • +1 more
        Jul 8, 2022

        Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in

        Not yet recruiting
        • Castration-Resistant Prostate Carcinoma
        • +2 more
        • Abiraterone Acetate/Niraparib
        • +5 more
        • Scottsdale, Arizona
          Mayo Clinic in Arizona
        Jan 9, 2023

        Myeloproliferative Neoplasia With Normal CBC and Thrombotic

        Recruiting
        • Thrombotic Patients
        • +2 more
          • Nantes, Loire-Atlantique, France
            Nantes University Hospital
          Sep 8, 2021

          Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

          Completed
          • Polycythemia Vera
          • +2 more
          • JAK2V617F mutation
          • Olomouc, Czechia
          • +29 more
          Dec 5, 2019

          Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

          Terminated
          Has Results
          • Primary Myelofibrosis
          • +2 more
          • Scottsdale, Arizona
          • +8 more
          Jul 9, 2021

          Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression

          Completed
          • Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression
          • JAK expression
          • Mansoura, Egypt
            Mansoura University Hospital
          Dec 9, 2020

          Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)

          Active, not recruiting
          • Chronic Myeloproliferative Neoplasms
          • Berlin, Germany
          • +14 more
          Jun 14, 2021

          Philadelphia Negative Myeloproliferative Tumors Trial

          Not yet recruiting
          • Philadelphia Negative Myeloproliferative Neoplasms
            • (no location specified)
            Jun 5, 2022

            Myeloproliferative Diseases Trial in Bergamo, Pavia (ITF2357)

            Completed
            Has Results
            • Myeloproliferative Diseases
            • Bergamo, Italy
            • +1 more
            Dec 2, 2019

            Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

            Recruiting
            • Myeloproliferative Neoplasms
            • Birmingham, Alabama
            • +16 more
            Jan 27, 2023

            Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

            Recruiting
            • Polycythemia Vera
            • Tianjin, China
              Institute of Hematology & Blood Diseases Hospital
            May 19, 2023

            Multiple Myeloma Trial in United States (Ruxolitinib Oral Tablet [Jakafi], Lenalidomide, Methylprednisolone)

            Recruiting
            • Multiple Myeloma
            • Ruxolitinib Oral Tablet [Jakafi]
            • +2 more
            • Alhambra, California
            • +12 more
            Apr 18, 2022